Literature DB >> 4050323

Multiple sclerosis--more than one disease?

J P Larsen, G Kvaale, T Riise, H Nyland, J A Aarli.   

Abstract

We have previously found an increase in prevalence and incidence of multiple sclerosis (MS) in the county of Hordaland, Western Norway. This study shows that the increase in incidence over a 30-year period is due to an increase of remittent and remittent/progressive MS. The incidence of the chronic progressive form of MS has remained stable during the same period. The two subgroups of MS also vary in symptomatology and age at onset. This suggests that MS has two different forms which behave differently when considered epidemiologically and clinically. The remitting and progressive forms may therefore each have a different etiology.

Entities:  

Mesh:

Year:  1985        PMID: 4050323     DOI: 10.1111/j.1600-0404.1985.tb00856.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors:  M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  The germline repertoire of T-cell receptor beta chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis.

Authors:  L Fugger; M Sandberg-Wollheim; N Morling; L P Ryder; A Svejgaard
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.

Authors:  O Olerup; J Hillert; S Fredrikson; T Olsson; S Kam-Hansen; E Möller; B Carlsson; J Wallin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

Authors:  G V McDonnell; S A Hawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

5.  MRI parameters in multiple sclerosis patients.

Authors:  I Reider-Groswasser; E Kott; J Benmair; M Huberman; Y Machtey; I Gelernter
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

6.  Incidence of multiple sclerosis: a periodic or stable phenomenon.

Authors:  H Meyer-Rienecker; F Buddenhagen
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

7.  Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Takahisa Masaki; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-01-02       Impact factor: 3.478

8.  HLA complement gene polymorphisms in multiple sclerosis. A study on 80 Italian patients.

Authors:  D Franciotta; E Dondi; R Bergamaschi; G Piccolo; G V d'Eril; V Cosi; M Cuccia
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

9.  Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.

Authors:  M Trojano; C Avolio; C Manzari; A Calò; F De Robertis; G Serio; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

10.  An immunogenetic heterogeneity in multiple sclerosis.

Authors:  J Hillert; M Grönning; H Nyland; H Link; O Olerup
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.